TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Enhancing Children's Cognitive and Brain Health Through Physical Activity Training
Brief Summary: The objective of this study is to use a randomized controlled design to determine whether cardiorespiratory fitness training improves neurocognitive function and academic performance during preadolescent development.


Options:
A: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity | Arm Label: Wait List Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Physical Activity | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Treatment Group | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Wait List Group
B: Arm Label: A+PAAC; Type: EXPERIMENTAL; Interventions: Behavioral: A+PAAC | Arm Label: CON; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CON | Intervention Type: BEHAVIORAL; Name: A+PAAC; Assigned to Arm(s): A+PAAC | Intervention Type: BEHAVIORAL; Name: CON; Assigned to Arm(s): CON
C: Intervention Type: BEHAVIORAL; Name: Nutritional and life style counseling; Assigned to Arm(s): N/A
D: Arm Label: CHL program; Type: EXPERIMENTAL; Interventions: Other: CHL program | Arm Label: Delayed Optimized CHL program; Type: OTHER; Interventions: Other: Delayed Optimized CHL program | Arm Label: Temporal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CHL program; Assigned to Arm(s): CHL program | Intervention Type: OTHER; Name: Delayed Optimized CHL program; Assigned to Arm(s): Delayed Optimized CHL program

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment. A 26-week Double-blind Placebo-controlled, Randomised, Multicentre, Multi-national, Parallel-group Trial
Brief Summary: This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of liraglutide in subjects with type 2 diabetes and moderate renal impairment.

The trial medication will be add-on to the subject's stable pre-trial OAD and/or insulin regimen.


Options:
A: N/A
B: Arm Label: Lira 1.8 mg; Type: EXPERIMENTAL; Interventions: Drug: liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Arm Label: Intensive glycemia control; Type: EXPERIMENTAL; Interventions: Drug: Hypoglycemic Agents | Arm Label: Standard glycemia control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard glycemia control | Arm Label: Intensive BP control; Type: EXPERIMENTAL; Interventions: Drug: Intensive BP treatment | Arm Label: Standard BP control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard BP control | Arm Label: Fibrate; Type: EXPERIMENTAL; Interventions: Drug: Fenofibrate, Drug: Simvastatin | Arm Label: Fibrate Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo | Intervention Type: DRUG; Name: Hypoglycemic Agents; Assigned to Arm(s): Intensive glycemia control | Intervention Type: DRUG; Name: Standard glycemia control; Assigned to Arm(s): Standard glycemia control | Intervention Type: DRUG; Name: Intensive BP treatment; Assigned to Arm(s): Intensive BP control | Intervention Type: DRUG; Name: Standard BP control; Assigned to Arm(s): Standard BP control | Intervention Type: DRUG; Name: Fenofibrate; Assigned to Arm(s): Fibrate | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): Fibrate, Fibrate Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Fibrate Placebo
D: Arm Label: aleglitazar; Type: EXPERIMENTAL; Interventions: Drug: aleglitazar | Arm Label: pioglitazone; Type: ACTIVE_COMPARATOR; Interventions: Drug: pioglitazone | Intervention Type: DRUG; Name: aleglitazar; Assigned to Arm(s): aleglitazar | Intervention Type: DRUG; Name: pioglitazone; Assigned to Arm(s): pioglitazone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment. A 26-week Double-blind Placebo-controlled, Randomised, Multicentre, Multi-national, Parallel-group Trial
Brief Summary: This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of liraglutide in subjects with type 2 diabetes and moderate renal impairment.

The trial medication will be add-on to the subject's stable pre-trial OAD and/or insulin regimen.


Options:
A: Arm Label: 1.5 mg Dulaglutide; Type: EXPERIMENTAL; Interventions: Drug: Dulaglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dulaglutide; Assigned to Arm(s): 1.5 mg Dulaglutide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Vildagliptin; Type: EXPERIMENTAL; Interventions: Drug: vildagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo of vildagliptin | Intervention Type: DRUG; Name: vildagliptin; Assigned to Arm(s): Vildagliptin | Intervention Type: DRUG; Name: placebo of vildagliptin; Assigned to Arm(s): Placebo
C: Arm Label: Placebo + metformin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Liraglutide + metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Liraglutide | Intervention Type: DRUG; Name: Liraglutide; Assigned to Arm(s): Liraglutide + metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + metformin
D: Arm Label: Lira 1.8 mg; Type: EXPERIMENTAL; Interventions: Drug: liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression
Brief Summary: The first part is a double-blind placebo-controlled trial to identify the effects of omega-3 polyunsaturated fatty acids (PUFAs) in prevention of IFN-induced depression. The second part is a double-blind trial to identify the antidepressant effects of omega-3 PUFAs in patients with IFN-induced depression.


Options:
A: Arm Label: n-3 Fatty Acid Supplemetation; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: n-3 Fatty Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: n-3 Fatty Acid; Assigned to Arm(s): n-3 Fatty Acid Supplemetation | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: EPA 3.5 g/day; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Omega-3 fatty acids | Arm Label: DHA 1.75 g/day; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Omega-3 fatty acids | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 fatty acids; Assigned to Arm(s): DHA 1.75 g/day, EPA 3.5 g/day, Placebo capsules
C: Arm Label: Infliximab; Type: EXPERIMENTAL; Interventions: Drug: Infliximab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): Infliximab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: EPA; Type: EXPERIMENTAL; Interventions: Dietary Supplement: EPA | Arm Label: DHA; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: DHA | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: EPA; Assigned to Arm(s): EPA | Intervention Type: DIETARY_SUPPLEMENT; Name: DHA; Assigned to Arm(s): DHA | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo capsules

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Symptom Management Program for Hemodialysis Patients
Brief Summary: Self-management intervention may decrease symptom burden and improve functioning over time.


Options:
A: Arm Label: Conventional hemodialysis; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional hemodialysis | Arm Label: Frequent hemodialysis; Type: EXPERIMENTAL; Interventions: Device: Frequent hemodialysis | Intervention Type: DEVICE; Name: Conventional hemodialysis; Assigned to Arm(s): Conventional hemodialysis | Intervention Type: DEVICE; Name: Frequent hemodialysis; Assigned to Arm(s): Frequent hemodialysis
B: Arm Label: Meditation Intervention Arm; Type: EXPERIMENTAL; Interventions: Other: Meditation | Arm Label: Control Group (No Meditation Exposure); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Meditation; Assigned to Arm(s): Meditation Intervention Arm
C: Arm Label: Self Management Strategies; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-management | Arm Label: Dietary Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary Information | Intervention Type: BEHAVIORAL; Name: Self-management; Assigned to Arm(s): Self Management Strategies | Intervention Type: BEHAVIORAL; Name: Dietary Information; Assigned to Arm(s): Dietary Information
D: Arm Label: HD treated with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Arm Label: post-dilution oHDF with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Arm Label: pre-dilution oHDF with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: HD treated with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: post-dilution oHDF with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: pre-dilution oHDF with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Intervention Type: DEVICE; Name: Citrate dialysate (CiDi); Assigned to Arm(s): HD treated with citrate dialysate, post-dilution oHDF with citrate dialysate, pre-dilution oHDF with citrate dialysate | Intervention Type: DEVICE; Name: Standard dialysate (StDi); Assigned to Arm(s): HD treated with standard dialysate, post-dilution oHDF with standard dialysate, pre-dilution oHDF with standard dialysate

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Symptom Management Program for Hemodialysis Patients
Brief Summary: Self-management intervention may decrease symptom burden and improve functioning over time.


Options:
A: Arm Label: CR845 0.5mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: CR845 0.5 mcg/kg | Arm Label: CR845 1 mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: CR845 1 mcg/kg | Arm Label: CR845 1.5mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: CR845 1.5mcg/kg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: CR845 0.5 mcg/kg; Assigned to Arm(s): CR845 0.5mcg/kg | Intervention Type: DRUG; Name: CR845 1 mcg/kg; Assigned to Arm(s): CR845 1 mcg/kg | Intervention Type: DRUG; Name: CR845 1.5mcg/kg; Assigned to Arm(s): CR845 1.5mcg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Self Management Strategies; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-management | Arm Label: Dietary Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary Information | Intervention Type: BEHAVIORAL; Name: Self-management; Assigned to Arm(s): Self Management Strategies | Intervention Type: BEHAVIORAL; Name: Dietary Information; Assigned to Arm(s): Dietary Information
C: Arm Label: turmeric; Type: EXPERIMENTAL; Interventions: Drug: turmeric | Arm Label: plasebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: turmeric; Assigned to Arm(s): turmeric | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): plasebo | Intervention Type: DRUG; Name: turmeric; Assigned to Arm(s): turmeric
D: Arm Label: Sarna Lotion; Type: EXPERIMENTAL; Interventions: Drug: Sarna | Arm Label: Placebo Cetaphil lotion; Type: PLACEBO_COMPARATOR; Interventions: Drug: Cetaphil | Intervention Type: DRUG; Name: Sarna; Assigned to Arm(s): Sarna Lotion | Intervention Type: DRUG; Name: Cetaphil; Assigned to Arm(s): Placebo Cetaphil lotion

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Parent Training to Address Pediatric Functional Abdominal Pain
Brief Summary: Functional abdominal pain (FAP) is a common complaint of childhood, associated with considerable health care costs, disruption of normal activity, emotional distress, and long-term health effects. The study will test a treatment approach which, if successful, would substantially change the treatment for FAP and potentially for a wide range of childhood medical problems where parental responses to symptoms contribute to these adverse effects. The study would also provide a model which would be much more accessible than traditional face-to-face therapies to a broader range of families in need than are currently served.


Options:
A: Arm Label: Standard of Care Observation Group; Type: N/A; Interventions: N/A | Arm Label: Biopsychosocial Intervention Group; Type: N/A; Interventions: Behavioral: Brief Cognitive-Behavioral Pain Management Training | Intervention Type: BEHAVIORAL; Name: Brief Cognitive-Behavioral Pain Management Training; Assigned to Arm(s): Biopsychosocial Intervention Group
B: Arm Label: Internet-based JIA Self-Management Program; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Taking Charge | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-Management | Intervention Type: BEHAVIORAL; Name: Teens Taking Charge; Assigned to Arm(s): Internet-based JIA Self-Management Program | Intervention Type: BEHAVIORAL; Name: Self-Management; Assigned to Arm(s): Attention Control Group
C: Arm Label: Wait List; Type: OTHER; Interventions: Behavioral: Wait list comparison group | Arm Label: 2 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 2 Family-based problem solving phone sessions | Arm Label: 4 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 4 Family-based problem solving phone intervention sessions | Intervention Type: BEHAVIORAL; Name: 2 Family-based problem solving phone sessions; Assigned to Arm(s): 2 phone sessions | Intervention Type: BEHAVIORAL; Name: 4 Family-based problem solving phone intervention sessions; Assigned to Arm(s): 4 phone sessions | Intervention Type: BEHAVIORAL; Name: Wait list comparison group; Assigned to Arm(s): Wait List
D: Arm Label: SLCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: SLCBT-R; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education and Support | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy & Social Learning; Assigned to Arm(s): SLCBT, SLCBT-R | Intervention Type: BEHAVIORAL; Name: Education and Support; Assigned to Arm(s): ES

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Parent Training to Address Pediatric Functional Abdominal Pain
Brief Summary: Functional abdominal pain (FAP) is a common complaint of childhood, associated with considerable health care costs, disruption of normal activity, emotional distress, and long-term health effects. The study will test a treatment approach which, if successful, would substantially change the treatment for FAP and potentially for a wide range of childhood medical problems where parental responses to symptoms contribute to these adverse effects. The study would also provide a model which would be much more accessible than traditional face-to-face therapies to a broader range of families in need than are currently served.


Options:
A: Arm Label: Wait List; Type: OTHER; Interventions: Behavioral: Wait list comparison group | Arm Label: 2 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 2 Family-based problem solving phone sessions | Arm Label: 4 phone sessions; Type: EXPERIMENTAL; Interventions: Behavioral: 4 Family-based problem solving phone intervention sessions | Intervention Type: BEHAVIORAL; Name: 2 Family-based problem solving phone sessions; Assigned to Arm(s): 2 phone sessions | Intervention Type: BEHAVIORAL; Name: 4 Family-based problem solving phone intervention sessions; Assigned to Arm(s): 4 phone sessions | Intervention Type: BEHAVIORAL; Name: Wait list comparison group; Assigned to Arm(s): Wait List
B: Arm Label: Coping Skills Training + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Skills Training, Drug: Amitriptyline | Arm Label: Headache Education + Amitriptyline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Headache Education, Drug: Amitriptyline | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills Training + Amitriptyline | Intervention Type: BEHAVIORAL; Name: Headache Education; Assigned to Arm(s): Headache Education + Amitriptyline | Intervention Type: DRUG; Name: Amitriptyline; Assigned to Arm(s): Coping Skills Training + Amitriptyline, Headache Education + Amitriptyline
C: Arm Label: Coping Skills; Type: EXPERIMENTAL; Interventions: Behavioral: Coping Skills Training | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Coping Skills Training; Assigned to Arm(s): Coping Skills | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education
D: Arm Label: SLCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: SLCBT-R; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education and Support | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy & Social Learning; Assigned to Arm(s): SLCBT, SLCBT-R | Intervention Type: BEHAVIORAL; Name: Education and Support; Assigned to Arm(s): ES

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Parent Training to Address Pediatric Functional Abdominal Pain
Brief Summary: Functional abdominal pain (FAP) is a common complaint of childhood, associated with considerable health care costs, disruption of normal activity, emotional distress, and long-term health effects. The study will test a treatment approach which, if successful, would substantially change the treatment for FAP and potentially for a wide range of childhood medical problems where parental responses to symptoms contribute to these adverse effects. The study would also provide a model which would be much more accessible than traditional face-to-face therapies to a broader range of families in need than are currently served.


Options:
A: Arm Label: Multisystemic Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Multisystemic Therapy | Arm Label: Standard Medical Care (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multisystemic Therapy; Assigned to Arm(s): Multisystemic Therapy
B: Arm Label: Teen Online Problem Solving; Type: EXPERIMENTAL; Interventions: Behavioral: Teen Online Problem Solving | Arm Label: Internet Resources Comparison; Type: EXPERIMENTAL; Interventions: Behavioral: Teen Online Problem Solving | Intervention Type: BEHAVIORAL; Name: Teen Online Problem Solving; Assigned to Arm(s): Internet Resources Comparison, Teen Online Problem Solving
C: Arm Label: SLCBT; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: SLCBT-R; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning | Arm Label: ES; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education and Support | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy & Social Learning; Assigned to Arm(s): SLCBT, SLCBT-R | Intervention Type: BEHAVIORAL; Name: Education and Support; Assigned to Arm(s): ES
D: Arm Label: Education with simulator; Type: EXPERIMENTAL; Interventions: Behavioral: Parent education with human patient simulator | Arm Label: Control arm: standard diabetes education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Parent education with human patient simulator; Assigned to Arm(s): Education with simulator | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Control arm: standard diabetes education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect Evaluation of a Theory and Evidence Based Programme for Establishing Effective Breastfeeding After Short Time Hospitalization Post Partum
Brief Summary: The purpose of this study is to evaluate if the developed theory and evidence based programme has a positive effect on mother's breastfeeding self efficacy, establishing an effective breastfeeding and breastfeeding duration after short time hospitalization.


Options:
A: Arm Label: Footlength Card; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Footlength Card | Arm Label: No Footlength Card; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Footlength Card; Assigned to Arm(s): Footlength Card
B: Arm Label: 3-week visit; Type: EXPERIMENTAL; Interventions: Other: 3-week visit | Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Intervention Type: OTHER; Name: 3-week visit; Assigned to Arm(s): 3-week visit | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): usual care
C: Arm Label: New breastfeeding programme; Type: EXPERIMENTAL; Interventions: Other: New Breastfeeding Counselling | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: OTHER; Name: New Breastfeeding Counselling; Assigned to Arm(s): New breastfeeding programme | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A

Answer: C